New combo therapy shows promise for advanced lung cancer patients
NCT ID NCT06293690
First seen Jan 11, 2026 · Last updated May 15, 2026 · Updated 19 times
Summary
This study tests whether combining the drug toripalimab with targeted radiation (SBRT) before surgery can shrink tumors in people with stage IIA to IIIB non-small cell lung cancer. The goal is to see if this approach leads to fewer cancer cells remaining after surgery. The trial involves 40 adults aged 18-75 who are healthy enough for surgery and have not spread cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, 200000, China
Conditions
Explore the condition pages connected to this study.